Metsera, Inc.
Clinical-stage biopharma developing peptide therapies for obesity and metabolic diseases.
MTSR | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 3 WORLD TRADE CENTER, 10007 NEW YORK
- Website:
- https://metsera.com/
- Sector:
- Manufacturing
Description
Metsera, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation medicines for obesity and related metabolic diseases. The company's portfolio includes both injectable and oral therapeutic candidates based on nutrient-stimulated hormone (NuSH) analog peptides. Leveraging a proprietary peptide engineering platform, Metsera aims to create potent, ultra-long-acting therapies with improved durability, bioavailability, and manufacturability. The company's approach is designed to deliver scalable treatments, including oral options with injectable-like performance, to enhance effectiveness, tolerability, and long-term patient adherence.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Metsera, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Metsera, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Metsera, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
